rosiglitazone has been researched along with Cancer of Cervix in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, Z; Park, WY; Yu, JR | 1 |
| Darrah, L; Ondrey, FG; Wudel, J; Wuertz, BR | 1 |
| Apgar, BS | 1 |
3 other study(ies) available for rosiglitazone and Cancer of Cervix
| Article | Year |
|---|---|
Rosiglitazone enhances radiosensitivity by inhibiting repair of DNA damage in cervical cancer cells.
Topics: Catalase; Cell Line, Tumor; Cell Survival; DNA Damage; DNA Repair; Female; Gene Expression Regulation, Neoplastic; Humans; Intracellular Space; Radiation Tolerance; Radiation-Sensitizing Agents; Reactive Oxygen Species; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones; Uterine Cervical Neoplasms | 2017 |
Thiazolidinediones abrogate cervical cancer growth.
Topics: Animals; Cell Differentiation; Cell Proliferation; Complement Factor D; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Mice; Papillomaviridae; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones; Uterine Cervical Neoplasms | 2017 |
Challenges of fragmented care in long-term management of pelvic pain.
Topics: Acetaminophen; Adult; Amines; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Chronic Disease; Continuity of Patient Care; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Drug Therapy, Combination; Endometriosis; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydrocodone; Hypoglycemic Agents; Interdisciplinary Communication; Pelvic Pain; Risk Factors; Rosiglitazone; Substance-Related Disorders; Thiazolidinediones; Trazodone; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2007 |